Skip to main content

Abstract

Physicians who prescribe psychotropic medications to children face unique legal and ethical challenges. The issues of competency, consent to treatment, patient autonomy, and confidentiality are important in this work, just as they are in adult medicine. The child and adolescent psychopharmacologist must also deal with the complex influences of family dynamics, child development, divorce, and custody as well as the involvement of parents, school personnel, and social service agencies in the treatment process. The fact that much remains to be understood in child psychiatry, the probabilistic rather than certain outcomes of medication trials, and the uncertain effects of new treatments on developing nervous systems all add additional layers of complexity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Keeton WP, Dobbs DB, Keeton RE, et al: Prosser & Keeton on Torts, ed 5. St. Paul, Minn, West Publishing Co, 1984.

    Google Scholar 

  2. Salgo vs Leland Stanford Jr. Univ. Board of Trustees, 317 P 2d 170 (Calif Ct App), 1957.

    Google Scholar 

  3. Natanson vs Kline, 186 Kans 393, 350 P 2d 1093, 1960.

    Google Scholar 

  4. Canterbury vs Spence, 464 F 2d 772 (DC Cir), 1972.

    Google Scholar 

  5. Jansen AR, Siegler M, Winslade WJ: Clinical Ethics, ed 2. New York, Macmillan, 1986.

    Google Scholar 

  6. Scarman L, quoted in Marsh BT: Informed consent: Help or hindrance? J R Soc Med 83:603–606, 1990.

    Google Scholar 

  7. Havard JDJ: The responsibility of the doctor. Br Med J 299:503–508, 1989.

    Article  Google Scholar 

  8. Appelbaum PS, Lidz CW, Meisel A: Informed Consent. London, Oxford University Press, 1987.

    Google Scholar 

  9. Harnish vs Children’s Hospital Medical Center, 387 Mass 152, 439 NE 2d 240, 1982.

    Google Scholar 

  10. Heneghan C: Consent to medical treatment. Lancet 337:421, 1991.

    Article  PubMed  Google Scholar 

  11. Popper C: Medical unknowns and ethical consent: Prescribing psychotropic medications for children in the face of uncertainty, in Popper C (ed): Psychiatric Pharmacosciences of Children and Adolescents. Washington DC, American Psychiatric Press, 1987, pp 127–161.

    Google Scholar 

  12. Campbell M, Grega DM, Green WH, et al: Neuroleptic-induced dyskinesias in children. Clin Neurophar-macol 6:207–222, 1983.

    Article  Google Scholar 

  13. Gualtieri CT, Barnhill J, McGimsey J, et al: Tardive dyskinesia and other movement disorder in children treated with psychotropic drugs. J Am Acad Child Psychiatry 19:491–510, 1980.

    Article  PubMed  Google Scholar 

  14. Beyer HA: Litigation and use of psychoactive drugs in developmental disabilities, in Aman MG, Singh NN (eds): Psychopharmacology of the Developmental Disabilities. Berlin, Springer-Verlag, 29–57, 1988.

    Chapter  Google Scholar 

  15. Golden GS: Tardive dyskinesia and developmental disabilities, in Aman MG, Singh NN (eds): Psychopharmacology of the Developmental Disabilities. Berlin, Springer-Verlag, 197–215, 1988.

    Chapter  Google Scholar 

  16. Mallary SD, Gert B, Culver CM: Family coercion and valid consent. Theor Med 7:123–126, 1986.

    Article  PubMed  Google Scholar 

  17. Appelbaum PS, Grisso T: Assessing patients’ capacities to consent to treatment. N Engl J Med 319:1635–1638, 1988.

    Article  PubMed  Google Scholar 

  18. Brahams D: Consent for treatment of minors in wardship. Lancet1 338:564–565, 1991.

    Article  Google Scholar 

  19. Kessel R: In the U.K., children can’t just say no. Hastings Center Report 23(2):20–21, 1993.

    Article  PubMed  Google Scholar 

  20. Dickinson D: Children’s informed consent to treatment: Is the law an ass? J Med Ethics 20:205–206, 222, 1994.

    Article  Google Scholar 

  21. Schleiffer vs Meyers, 644 F 2d 656 (7th Cir), 1981, cert den 454 US 823, 102 S Ct 110.

    Google Scholar 

  22. Parham vs J.R., 442 US 584, 1979.

    Google Scholar 

  23. R.J.D. vs Vaughan Clinic, P.C., 572 So 2d 1225 (Ala Sup Ct), 1990.

    Google Scholar 

  24. In re Roger S., 141 Calif Rptr 298, 569 P 2d 1286 (Calif S Ct), 1977.

    Google Scholar 

  25. Corpus Juris Secundum, Parent and Child Sec 16.

    Google Scholar 

  26. Hart vs Brown, 29 Conn Sup 368, 289 A 2d 386 (Conn Sup), 1972.

    Google Scholar 

  27. Melville vs Sabbatino, 30 Conn Sup 320, 313 A 2d 886 (Conn Sup), 1973.

    Google Scholar 

  28. In re Sampson, 65 Mise 2d 658, 317 NYS 2d 641, 1970, aff’d 29 NY 2d 900, 278 NE 2d 918, 1972.

    Google Scholar 

  29. In re Green, 448 Pa 338, 292 A 2d 387, 1972.

    Google Scholar 

  30. Custody of a Minor, 375 Mass 733, 375 NE 2d 373, 1978.

    Google Scholar 

  31. Kluge EH: Informed consent by children: The new reality. Can Med Assoc J 152:1495–1497, 1995.

    Google Scholar 

  32. Redding RE: Children’s competence to provide informed consent for mental health treatment. Washington & Lee Law Review 50:695–753, 1993.

    Google Scholar 

  33. Koocher GP: Children under the law: The paradigm of consent, in Melton GB (ed): Reforming the Law. New York, Guilford Press, 1987.

    Google Scholar 

  34. Holder AR: Disclosure and consent problems in pediatrics. Law Med Health Care 16:219–228, 1988.

    PubMed  Google Scholar 

  35. Corpus Juris Secundum, Parent and Child Sec 5–9.

    Google Scholar 

  36. Massachusetts General Laws, Ch 112 Sec 12F.

    Google Scholar 

  37. Code of Virginia, Art 15 Sec 16.1–334, 1990.

    Google Scholar 

  38. Baird vs Attorney General, 371 Mass 741, 360 NE 2d 288, 1971.

    Google Scholar 

  39. Arizona Laws of 1962, Title 44 Sec 44–133.01.

    Google Scholar 

  40. Arizona Laws of 1971, Title 44 Sec 44–132.01.

    Google Scholar 

  41. Code of Virginia, Art 6 Sec 54.1–2969.

    Google Scholar 

  42. Weithorn LA, Campbell SB: The competency of children and adolescents to make informed treatment decisions. Child Dev 53:1589–1598, 1982.

    Article  PubMed  Google Scholar 

  43. Dorn LD, Susman EJ, Fletcher JC: Informed consent in children and adolescents: Age, motivation and psychological state. J Adolesc Health 16:185–190, 1995.

    Article  PubMed  Google Scholar 

  44. Cauffman E, Steinberg L: The cognitive and affective influences on adolescent decision making. Temple Law Review 68:1763–1789, 1995.

    Google Scholar 

  45. American Academy of Pediatrics Committee on Broethics: Informed consent, parental permission, and assent in pediatric practice. Pediatrics 95(2):314–317, 1995.

    Google Scholar 

  46. Rogers vs Commissioner of the Department of Mental Health, 390 Mass 489, 458 NE 2d 308, 1983.

    Google Scholar 

  47. Appelbaum PS: The right to refuse treatment with antipsychotic medication: Retrospect and prospect. Am J Psychiatry 145:413–419, 1988.

    PubMed  Google Scholar 

  48. Guardianship of Roe, 383 Mass 415, 421 NE 2d 40, 1981.

    Google Scholar 

  49. 110 Code of Massachusetts Regulations 11.00.

    Google Scholar 

  50. Barnum R: Decision making for children: The regulation of psychopharmacological treatment for children in public custody in Massachusetts. Mass Family Law J 7:21–31, 1989.

    Google Scholar 

  51. Zummo vs Zummo, 394 Pa S 30, 574 A 2d 1130 (Pa Super), 1990.

    Google Scholar 

  52. Durfee vs Durfee, 194 Misc 594, 87 NYS 2d 275 (NY S Ct), 1949.

    Google Scholar 

  53. Bernet W: The noncustodial parent and medical treatment. Bull Am Acad Psychiatry Law 21(3):357–364, 1993.

    PubMed  Google Scholar 

  54. Weinstock R, Leong GB, Silva JA: Confidentiality and privilege, in Simon RI (ed): Review of Clinical Psychiatry and the Law. Washington DC, American Psychiatric Association Press, 1990, vol 1, pp 90–98.

    Google Scholar 

  55. Coyte PC, Dewees DN, Trebilcock MJ: Medical malpractice—The Canadian experience. N Engl J Med 324:89–93, 1991.

    Article  PubMed  Google Scholar 

  56. Danzón PM: The “crisis” in medical malpractice: A comparison of trends in the United States, Canada, the United Kingdom, and Australia. Law Med Health Care 18:48–58, 1990.

    PubMed  Google Scholar 

  57. Quam L, Fenn P, Dingwale R: Medical malpractice in perspective II—The implications for Britain. Br Med J 294:1597–1600, 1987.

    Article  Google Scholar 

  58. Tan MW, McDonough VJ: Risk management in psychiatry. Psychiatric Clin North Am 13:135–147, 1990.

    Google Scholar 

  59. Tarasoff vs Regents of University of California, 17 Calif 3d 425, 551 P 2d 334, 1976.

    Google Scholar 

  60. Schouten R: Informed consent: Resistance and reappraisal. Crit Care Med 17:1359–1361, 1989.

    PubMed  Google Scholar 

  61. Gutheil TG, Bursztajn H, Brodsky A: Liability prevention through the sharing of uncertainty: Informed consent and the therapeutic alliance. N Engl J Med 311:49–51, 1984.

    Article  PubMed  Google Scholar 

  62. Appelbaum PS, Gutheil TG: Clinical Handbook of Psychiatry and the Law. Baltimore, Williams & Wilkins, 1991.

    Google Scholar 

  63. Woods vs Brumlop, 377 P 2d 520 (NM), 1962.

    Google Scholar 

  64. Gutheil TG: On apologizing to patients. Risk Manage Found Forum 8:3–4, 1987.

    Google Scholar 

  65. Weaver vs. Reagen, 886 F. 2d 194 (C.A. 8, 1989).

    Google Scholar 

  66. Rayburn WF: A physician’s preogative to prescibe drugs for off-label uses during pregnancy. Obstet Gynecol 81:1052–1055, 1993.

    PubMed  Google Scholar 

  67. Stoffelmayr KJ: Products liability and “off-label” uses of prescription drugs. University of Chicago Law Review 63:275–306, 1996.

    Article  Google Scholar 

  68. American Academy of Pediatrics Committee on Drugs: Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration: Subject review. Pediatrics 98(1):143–145, 1996.

    Google Scholar 

  69. Torres A: The use of Food and Drug Administration-approved medications for unlabelled (off-label) uses. Arch Dermatol 130:32–36, 1994.

    Article  PubMed  Google Scholar 

  70. Klein vs. Biscup, 109 Ohio App.3d 855, 673 N.E.2d 225 (Ohio App. 8 Dist).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schouten, R., Duckworth, K.S. (1999). Medicolegal and Ethical Issues in the Pharmacologic Treatment of Children. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0086-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0086-9_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45885-9

  • Online ISBN: 978-1-4899-0086-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics